Pulling SEC filings + quote and writing the call…

STEVEN MADDEN, LTD.
Next earnings Jul 28, 2026 (before open) · consensus $0.32 EPS, $646M rev
Last earnings +6.2% on 2026-05-06
Kurt Geiger deal lifted sales but gutted earnings; healthy cash flow and undemanding P/S keep it a hold, not a buy.
Revenue (FY2025) $2.52B · FY2025
Middling fundamentals and a rich price (~89% above fair value) leave little margin of safety — a wait-and-see.
Steven Madden's FY2025 looks like a tale of two income statements. Revenue grew a solid 11.0% to $2.52B — the fifth straight year of expansion off the 2021 base of $1.85B — yet net income collapsed 72.1% to $49.0M and diluted EPS fell 73.2% to $0.63. The headline 67.6x P/E is therefore an artifact of trough earnings, not a real valuation signal. The driver is plain in the MD&A: the May 2025 acquisition of Kurt Geiger for ~$403M, plus new Australia/Malaysia JV consolidations. That deal swung the balance sheet hard — total assets +35.6%, total liabilities +88.6%, cash down 40.8% to $112M — and was funded by an Amended Credit Agreement with a $300M term loan and $250M revolver. Operating margin compressed to 3.2% from a historical high-single-digit/low-double-digit norm, the clearest sign the profit hit is acquisition- and integration-driven rather than a demand collapse.
Crucially, the franchise still generates cash: operating cash flow was $162M, comfortably covering the $61.0M dividend and $13.5M of (sharply reduced) buybacks. The balance sheet is leveraged but not stressed — liabilities/equity 1.17x, long-term debt $234M against $866M equity, and management states all covenants (Total Net Leverage max 3.00x, Fixed Charge Coverage min 1.25x) were within thresholds at 12/31/2025. So this is a quality brand that levered up to buy growth, swallowing a brutal earnings year in the process.
Is SHOO a buy? The one-page verdict, explained →
HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $1.85B | $2.11B | $1.97B | $2.27B | $2.52B |
| Gross profit | $767M | $874M | $832M | $937M | $1.05B |
| Operating income | $244M | $282M | $213M | $225M | $80.8M |
| Net income | $192M | $217M | $174M | $176M | $49.0M |
| Diluted EPS | $2.34 | $2.77 | $2.30 | $2.35 | $0.63 |
| Net margin | 10.4% | 10.3% | 8.8% | 7.7% | 1.9% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Annual meeting vote results (Item 5.07); directors elected, routine items passed
Q1 FY2026: Kurt Geiger consolidated, higher debt and leverage vs prior year
Q1 FY2026 earnings released; first quarter fully consolidating Kurt Geiger
2026 proxy: board nominees, exec comp and say-on-pay for annual meeting
FY2025: revenue +11% but net income -72%; $403M Kurt Geiger buy, new $550M facility
Q4/FY2025 results released; net income fell ~72% on margin and integration pressure
Officer/director change announced (Item 5.02 management transition)
Q3 FY2025: Kurt Geiger integration weighing on margins and cash
Q3 FY2025 earnings released amid integration costs and margin compression
Sources: SEC EDGAR (CIK 0000913241, latest 10-Q filed 2026-05-08) · EODHD · Proprietary analysis · as of 6/29/2026, 10:39:33 PM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 29, 2026, 6:39 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 7 sales
| 2026-06-15 | MIGLIORINI PETER Director | Sell | 4.00K @ $45.30 | $181K |
| 2026-06-15 | Reed Arian Simone Director | Sell | 1.10K @ $45.38 | $49.9K |
| 2026-06-09 | Ciglar Christina Chief Product Officer | Sell | 5.15K @ $44.74 | $230K |
| 2026-06-04 | Reed Arian Simone Director | Sell | 475.00 @ $43.82 | $20.8K |
| 2026-06-03 | VARELA AMELIA President | Sell | 10.0K @ $43.45 | $434K |
| 2026-05-22 | Davis Peter Allan Director | Sell | 3.03K @ $41.98 | $127K |
| 2026-05-20 | Reed Arian Simone Director | Sell | 648.00 @ $39.97 | $25.9K |
| 2026-05-20 | Reed Arian Simone Director | Award | 2.96K | |
| 2026-05-20 | Sachdev Ravi Director | Award | 2.96K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median